Accueil
Mots-clés
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
Les communications présentées lors de cette journée ont abordé les thèmes suivants : les effets stimulants de la nicotine sur la cognition chez l'homme et leur étude par les techniques de potentiels évoqués (ERP) qui permettent l'exploration des[...]Article : Périodique
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE |2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]Congrès
MAYHEW D. R. ; International Council on Alcohol, Drugs and Traffic Safety, Organisateur de réunion, de conférence ; C. DUSSAULT ; T'2002. Proceedings of the 16th international conference on alcohol, drugs and traffic safety (August 4-9, 2002; Montréal) | International Council on Alcohol, Drugs and Traffic Safety (ICADTS) | 2002Périodique
J. RAMSEY ; A. JOHNSTON | 1998FRANÇAIS : La pharmacocinétique des drogues est influencée par les réactions du corps de l'usager, mais aussi par la présence d'autres substances, drogues ou médicaments. Cette feuille d'information indique les interactions les plus communes en[...]Article : Périodique
Substituted phenethylamines are a class of designer drugs that hold a significant position in the drug abuse market. The most important substances within this class appear to be 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its novel derivative[...]Article : Périodique
Substituted phenethylamines are a class of designer drugs that have recently emerged in the drug abuse market. Such substances remain legal to use, possess, and supply until these compounds become classified as scheduled. 2C-I-NBOMe or 25I-NBOMe[...]Rapport
M. BAGGOTT ; L. JEROME ; R. STUART | Sarasota : MAPS ; Multidisciplinary Association for Psychedelic Studies | 2001This document is divided into five chapters, each summarizing an area of MDMA research: clinical studies; information on illicit users, neurotoxicity research in animals; neurotoxicity research in humans; and adverse events in illicit users. App[...]Périodique
R. MAYER ; P. ZUCCARO ; R. PACIFICI | 1999FRANÇAIS : L'ecstasy est une substance dont beaucoup de jeunes font une consommation abusive, essentiellement en boites de nuit. C'est un dérivé synthétique d'amphétamine, classé parmi les drogues de synthèse et les substances empathogènes. Il [...]Article : Périodique
Aims: To investigate the temporal pattern of appearance of a new psychoactive substance (4-fluoroamphetamine) on the Dutch drug market, as well as its patterns of use and effects. Design: Data from the Drug Information and Monitoring System (DI[...]Article : Périodique
Objective: 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-dimethylaminorex (4,4'-DMAR)) is a derivative of the controlled substances aminorex and 4-methylaminorex marketed as a potential novel psychoactive substance. This paper brin[...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Article : Périodique
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO |OBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]Article : Périodique
A. TURCANT ; M. DEGUIGNE ; S. FÉREC ; C. BRUNEAU ; I. LEBORGNE ; B. LELIÈVRE ; C. GEGU ; F. JEGOU ; C. ABBARA ; G. LE ROUX ; D. BOELS |For the last 10 years, recreational use of new psychoactive substances (NPS) with hallucinogenic properties was more and more described either in a context of consumption during a rave-party or at home alone or in small group. A review of 62 cas[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]
